Earnings win
$Rain Oncology (RAIN.US)$ reported quarterly losses of $(0.19) per share which beat the analyst consensus estimate of $(0.27) by 29.63 percent. This is a 72.06 percent increase over losses of $(0.68) per share from the same period last year.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
PYUN970IHaveChosen :